Bio21's Associate Professor Neil O’Brien-Simpson and Professor Eric Reynolds from the Faculty of Medicine, Dentistry and Health Sciences and Bio21 Institute were on the team that created the star-shaped ‘peptide polymer’ structures that hold promise for a new treatment methods against superbugs.

Congratulations to Bio21's Kat Holt, recipient of the Georgina Sweet Award for Quantitative Biomedical Science.

Bio21's Professor Paul Mulvaney is the new Director of the Centre of Excellence in Exciton Science.

If we are to help wildlife and ecosystems survive in the future, we’ll have to rethink our parks and reserves.

Read Professor Andrew Holme's piece published in The Conversation.

Professor Paul Gleeson was Head of the Department of Biochemistry and Molecular Biology from 2006 to 1 June, 2016.

Bio21's Michael Parker is part of an international collaboration that has shown how the bacteria Gardnerella vaginalis targets cells and causes infection in women

Research linking cancer drugs to overcoming drug-resistant malaria puts team in contention for Eureka Prize

The Honourable Frank McGuire, Jan Tennent, CEO of BioMedVic and Professor Ian Gust, former Head of CSL’s Research and Development division, in the Bio21 atrium.

Kevin Cheung and Zara Tse report on a week of work experience at Bio21 Institute, 27th June - 1st July 2016.